-
-
公开(公告)号：KR1020160051274A
公开(公告)日：2016-05-11
申请号：KR1020140150909
申请日：2014-11-03
Applicant: (주)아모레퍼시픽
CPC classification number: A61K36/82 , A61K8/66 , A61K8/9789 , A61Q19/00 , A61Q19/008
Abstract: 본발명은차나무뿌리유래사포닌분획물을함유하는조성물에관한것으로서, 보다상세하게는차나무뿌리추출물을효소로처리한다음분리한사포닌분획물을사용함으로써기존차나무뿌리에서추출한사포닌분획물에비하여세포독성을저감시켜피부에대한안전성을높이고, 이와같이얻은사포닌분획물을조성물에더 높은수준으로포함시킬수 있어더 우수한피부상태개선효과를제공할수 있는조성물에관한것이다.
Abstract translation: 本发明涉及含有来自酶处理的茶树根的皂角苷成分的组合物。 更具体地说，本发明涉及能够提供皮肤改善皮肤状况的优异效果的组合物。 为此，使用酶处理茶树根提取物后分离出的皂角苷成分，与从茶树根中提取的现有皂苷成分相比，具有更好的降低细胞毒性的作用。 因此，皮肤的安全性增加，因此可以在组合物中加入更多的皂角苷含量。
-
公开(公告)号：KR1020140115140A
公开(公告)日：2014-09-30
申请号：KR1020130029861
申请日：2013-03-20
Applicant: (주)아모레퍼시픽
Abstract: The present invention relates to a composition for scalp or hair, and more specifically, to a composition for scalp or hair, which uses disodium R-glucose-sulfosuccinate as a surfactant and stabilizes sensitive, irritant, or reactive scalps, thereby making the scalp healthy, giving strength to hair, and enhancing the hair roots.
Abstract translation: 本发明涉及一种头皮或毛发用组合物，更具体地，涉及使用R-葡萄糖 - 磺基琥珀酸二钠作为表面活性剂的头皮或毛发用组合物，稳定敏感，刺激性或反应性的头皮，从而使头皮健康 赋予头发力量，增强发根。
-
公开(公告)号：KR1020080051201A
公开(公告)日：2008-06-11
申请号：KR1020060121861
申请日：2006-12-05
Applicant: (주)아모레퍼시픽
IPC: A61K31/685 , A61K31/661
CPC classification number: A61K31/688 , Y10S514/863 , Y10S514/886
Abstract: A pharmaceutical composition comprising sphingosylphosphorylcholine or derivatives thereof is provided to inhibit proliferation and promote differentiation of keratinocyte, inhibit proliferation of splenocyte and T cell, induce reduction of leucocyte, and reduce mouse ear swelling induced by TPA(tetradecanoyl phorbol acetate), so that the composition is useful for treating psoriasis. A pharmaceutical composition for treating psoriasis comprises sphingosylphosphorylcholine(SPC) represented by the formula(1) or derivatives thereof and is formulated as tablet, pill, powder, sachet, elixir, suspension, emulsion, solution, syrup, aerosol, soft or hard gelatin capsule, sterile injection or sterile powder, wherein the daily dosage is 1-100 mg/kg, preferably 5-70 mg/kg.
Abstract translation: 提供包含鞘氨醇磷酰胆碱或其衍生物的药物组合物，以抑制角质形成细胞的增殖和促进分化，抑制脾细胞和T细胞的增殖，诱导白细胞的减少，并减少TPA（十四酰基佛波醇乙酸酯）诱导的小鼠耳肿胀，使组合物 可用于治疗牛皮癣。 用于治疗牛皮癣的药物组合物包含由式（1）表示的鞘糖基磷酰胆碱（SPC）或其衍生物，并配制成片剂，丸剂，粉末，小药囊，酏剂，悬浮液，乳剂，溶液，糖浆，气雾剂，软或硬明胶胶囊 无菌注射或无菌粉末，其中日剂量为1-100mg / kg，优选5-70mg / kg。
-
公开(公告)号：KR101481177B1
公开(公告)日：2015-01-09
申请号：KR1020080119251
申请日：2008-11-28
Applicant: (주)아모레퍼시픽
Abstract: 금전초 추출물(Glechoma hederacea extract), 페퍼민트 추출물 및 바이오사카라이드 검-2의 혼합물을 포함하여 자극 및 피부 자극감을 완화시키는 효능을 가지는 화장료 조성물을 개시한다. 상기 화장료 조성물은 항염 효과, 자극 완화 효과 및 피부 자극감 완화 효과를 갖는다.
자극 완화, 금전초, 페퍼민트 추출물, 바이오사카라이드 검-2, 민감성 피부, 화장품-
Patent Agency Ranking
公开(公告)号：KR1020110013126A
公开(公告)日：2011-02-09
申请号：KR1020090096071
申请日：2009-10-09
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/97 , A61K9/0014 , A61K36/53 , A61K36/752 , Y10S514/844 , Y10S514/857 , Y10S514/886
Abstract: PURPOSE: A composition containing Glechoma hederacera extract or Boerhavia diffusa extract for relieving skin irritation or inflammation is provided to be used in cosmetic or pharmaceutical field. CONSTITUTION: A composition for relieving skin irritation or inflammation contains Boerhavia diffusa extract, Glechoma hederacera extract or Citrus Grandis extract as an active ingredient. The weight ratio of the extract of Glechoma hederacera, Citrus Grandis and Boerhavia diffusa is 1-20:1-20:1-10. The Glechoma hederacera extract is obtained from root or leave of Glechoma hederacera. The Boerhavia diffusa extract is obtained from root and leaves of Boerhavia diffusa extract. The Citrus Grandis extract is obtained from Citrus Grandis fruit.
Abstract translation: 目的：提供用于缓解皮肤刺激或炎症的含有Glechoma hederacera提取物或Boerhavia diffusa提取物的组合物用于化妆品或制药领域。 构成：用于缓解皮肤刺激或炎症的组合物含有Boerhavia diffusa提取物，Glechoma hederacera提取物或Citrus Grandis提取物作为活性成分。 Glechoma hederacera，Citrus Grandis和Boerhavia diffusa的提取物的重量比为1-20：1-20：1-10。 Glechoma hederacera提取物从Glechoma hederacera的根或离开获得。 Boerhavia diffusa提取物从Boerhavia diffusa提取物的根和叶获得。 Citrus Grandis提取物是从Citrus Grandis水果中获得的。
-
公开(公告)号：KR1020100005481A
公开(公告)日：2010-01-15
申请号：KR1020080065530
申请日：2008-07-07
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition for improving hair and scalp condition is provided to ensure sedation effect to itch, inflammation, and irritation and have excellent hair conditioning effect. CONSTITUTION: A composition for improving scalp and hair condition contains 0.005-50 weight% of ingredient or more selected from cationic surfactant, xylitol, zinc oxide, Glycyrrhiza uralensis extract, Bridal wreath extract, and Portulaca oleracea L. extract as an active ingredient. The cationic surfactant is quaternary ammonium or tertiary amidoamine. The composition is used in the form of hair tonic, scalp treatment, hair treatment, hair rinse, hair shampoo, hair cream, hair lotion, scalp pack, and ample.
Abstract translation: 目的：提供改善头发和头皮状况的组合物，以确保瘙痒，炎症和刺激的镇静作用，并具有优异的头发调理效果。 构成：用于改善头皮和头发状况的组合物含有0.005-50重量％的成分或更多选自阳离子表面活性剂，木糖醇，氧化锌，甘草提取物，新娘花环提取物和马齿苋提取物作为活性成分。 阳离子表面活性剂是季铵或叔胺酰胺。 该组合物以头发补品，头皮治疗，头发处理，头发冲洗，头发洗发剂，发霜，头发洗剂，头皮包装和充足的形式使用。
-
公开(公告)号：KR100879411B1
公开(公告)日：2009-01-19
申请号：KR1020060065840
申请日：2006-07-13
Applicant: (주)아모레퍼시픽 , 에스비사이언스(주)
IPC: A61K31/131 , A61P17/02
Abstract: 본 발명은 하기 화학식 1로 표시되는 2-아미노-2-옥틸옥시메틸-프로판-1,3-디올(2-amino-2-octyloxymethyl-propane-1,3-diol, AOOMP) 또는 이의 약학적으로 허용 가능한 염을 포함하는, 스핑고실포스포릴콜린(sphingosylphosphorylcholine, SPC)의 작용을 억제하는 약학 조성물에 관한 것이다.
본 발명에 따른 약학 조성물은 SPC의 생체내 및 생체외 작용에 따른 세포 분열 증식, 염증 반응, 히스타민 분비 또는 가려움증 등을 효과적으로 억제하고, 투여시 심장 박동수의 저하와 같은 부작용이 없으므로, 외상 후의 흉터 형성 억제 및 아토피성 피부염 또는 기타 질환에서 나타나는 염증, 소양증, 및 피부 감염증 등의 예방 및 치료에 유용하게 사용될 수 있다.-
公开(公告)号：KR1020080006737A
公开(公告)日：2008-01-17
申请号：KR1020060065840
申请日：2006-07-13
Applicant: (주)아모레퍼시픽 , 에스비사이언스(주)
IPC: A61K31/131 , A61P17/02
Abstract: A pharmaceutical composition is provided to effectively inhibit cell proliferation, inflammatory reaction, histamine secretion or itch caused by the function of sphingosylphosphorylcholine without side effects, thereby being usefully used for inhibiting scar formation after wound and preventing and treating inflammation, pruritus and skin inflammatory diseases. A pharmaceutical composition for inhibiting the function of sphingosylphosphorylcholine comprises 2-amino-2-octyloxymethyl-propane-1,3-diol represented by the formula(1) or a pharmaceutically acceptable salt thereof. The composition further comprises a carrier, an excipient or a diluent.
Abstract translation: 提供药物组合物以有效地抑制由鞘脂酰磷酰胆碱的功能引起的细胞增殖，炎症反应，组胺分泌或瘙痒，无副作用，从而有效地用于抑制伤口后的瘢痕形成，预防和治疗炎症，瘙痒和皮肤炎症性疾病。 用于抑制鞘糖基磷酰胆碱功能的药物组合物包含由式（1）表示的2-氨基-2-辛氧基甲基 - 丙烷-1,3-二醇或其药学上可接受的盐。 组合物还包含载体，赋形剂或稀释剂。
-
-
-
-
-
-
-
-
-
Search Results
35
records
(took 0.026 seconds)
